Onderneming Sonnet BioTherapeutics Holdings, Inc.
Aandelen
SONN
US83548R3030
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,76 USD | -1,68% | -5,38% | +1,15% |
11/03 | Handelaren anticiperen op inflatierapport terwijl Amerikaanse aandelen lager openen op Wall Street | MT |
11/03 | Top premarket stijgers | MT |
Vakgebied
Aantal werknemers: 12
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Cini
FOU | Founder | 72 | 01-01-11 |
Pankaj Mohan
CEO | Chief Executive Officer | 60 | 01-04-20 |
Jay Cross
DFI | Director of Finance/CFO | 53 | 01-05-19 |
Manuel Dafonseca
CTO | Chief Tech/Sci/R&D Officer | - | 22-03-21 |
Richard Kenney
CTO | Chief Tech/Sci/R&D Officer | 66 | 01-04-21 |
Susan Dexter
CTO | Chief Tech/Sci/R&D Officer | 67 | 01-04-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Raghu Rao
BRD | Director/Board Member | 62 | 01-04-20 |
Pankaj Mohan
CEO | Chief Executive Officer | 60 | 01-04-20 |
Donald Griffith
BRD | Director/Board Member | 75 | 01-04-20 |
Albert Dyrness
BRD | Director/Board Member | 61 | 01-04-20 |
Nailesh Bhatt
BRD | Director/Board Member | 52 | 01-04-20 |
Lori McNeill
BRD | Director/Board Member | 51 | 25-09-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 3 069 516 | 2 786 509 ( 90,78 %) | 0 | 90,78 % |
Bedrijfsgegevens
Sonnet BioTherapeutics Holdings, Inc.
100 Overlook Center Suite 102
08540, Princeton
+
http://www.sonnetbio.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,15% | 5,49 mln. | |
+32,95% | 700 mld. | |
+26,51% | 569 mld. | |
-4,97% | 358 mld. | |
+18,83% | 330 mld. | |
+3,54% | 287 mld. | |
+15,70% | 236 mld. | |
+6,68% | 202 mld. | |
-9,08% | 197 mld. | |
+6,70% | 161 mld. |
- Beurs
- Aandelen
- Koers SONN
- Onderneming Sonnet BioTherapeutics Holdings, Inc.